Overview

Drug-Drug Interaction Study of VCH-222 and Telaprevir in Healthy Subjects

Status:
Completed
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the pharmacokinetics, safety, and tolerability of the co-administration of VCH-222 and telaprevir in healthy subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Vertex Pharmaceuticals Incorporated